WithdrawnPhase 2NCT02092142

Safety and Immunogenicity of Q Fever Vaccine

Studying Q fever

Last synced from ClinicalTrials.gov May 20, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: U.S. Army Medical Research and Development Command
Principal Investigator: Mark J Goldberg, MD
Special Immunizations Program, USAMRIID
Intervention: Q fever Vaccine(biological)
Eligibility: 18 years · All sexes
Timeline: 2006 – 2019

Study locations (1)

Special Immunizations Program, Division of Medicine, USAMRIID, Fort Deterick, Maryland, United States

Collaborators

US Army Medical Research Institute of Infectious Diseases

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02092142 on ClinicalTrials.gov

← Back to all trials